SCHEMBL6465008

SCHEMBL6465008

N#COc1ccc(Br)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.42
MAPT P10636 2/20 0.41
MAOA P21397 4/20 0.39
MAOB P27338 4/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
LDHA P00338 1/20 0.35
MAPK1 P28482 2/20 0.34
RECQL P46063 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ALDH1A1 P00352 2/20 0.33
ALOX15 P16050 2/20 0.33
APP P05067 1/20 0.33
ERBB2 P04626 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24787 0.86 CA1 (0.32) MAPTMAOBCA1CA2CA9
SCHEMBL6056082 0.78 KMT2A (0.41) MAPTMAOAMAPK1MEN1LMNA
SCHEMBL2589097 0.78 KMT2A (0.41) MAPTMAOAMAPK1MEN1LMNA
SCHEMBL184515 0.78 MMP2 (0.34) MAPK1RAB9AALDH1A1
SCHEMBL184373 0.78 KMT2A (0.41) MAPTMAOAMAPK1MEN1LMNA
SCHEMBL15436098 0.76
SCHEMBL7937190 0.74 ALDH1A1 (0.50) MAPTMAOAMAOBMAPK1MEN1
SCHEMBL764016 0.74 ACHE (0.48) CYP2A6MAPTCA1CA2CA9
SCHEMBL3418060 0.74 CA1 (0.30) CA1CA2CA9
SCHEMBL19205443 0.74 IDO1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0581268-B1 Flame-retarded thermosetting resin composition, prepregs and electrical laminates made therefrom KANEGAFUCHI CHEMICAL IND (JP) 1997-12-29 EP claimed
EP-0581268-A1 Flame-retarded thermosetting resin composition, prepregs and electrical laminates made therefrom KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-02-02 EP claimed
EP-4683909-A2 ATM KINASE INHIBITORS Eberhard Karls Universität Tübingen (DE) 2026-01-28 EP disclosed
US-20260015328-A1 ATM KINASE INHIBITORS EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) 2026-01-15 US disclosed
WO-2024194460-A2 ATM KINASE INHIBITORS EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2024-09-26 WO disclosed
EP-4434972-A1 ATM KINASE INHIBITORS Eberhard-Karls-Universität Tübingen (DE) 2024-09-25 EP disclosed
US-20230348462-A1 IMIDAZO[4,5-C]QUINOLINE COMPOUNDS AND THEIR USE AS ATM KINASE INHIBITORS DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2023-11-02 US disclosed
US-20210022340-A1 USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY THE NATIONAL INSTITUTE OF PARASITIC DISEASES, CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION (CN) 2021-01-28 US disclosed
US-20180162823-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-14 US disclosed
US-9926282-B2 Phthalazinones and isoquinolinones as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-27 US disclosed
US-20180000788-A1 CYCLIC UREAS AS INHIBITORS OF ROCK BRISTOL MYERS SQUIBB CO (US) 2018-01-04 US disclosed
US-20140206686-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-07-24 US disclosed
US-6853790-B1 Optical waveguides derived from a combination of poly(perfluorocyclobutanes) and polymeric cyanates PIRELLI CAVI E SISTEMI S.P.A. (IT) 2005-02-08 US disclosed
EP-1198724-A1 OPTICAL WAVEGUIDES DERIVED FROM A COMBINATION OF POLY(PERFLUOROCYCLOBUTANES) AND POLYMERIC CYANATES PIRELLI CAVI E SISTEMI S.p.A. (IT) 2002-04-24 EP disclosed
WO-2001002879-A1 OPTICAL WAVEGUIDES DERIVED FROM A COMBINATION OF POLY(PERFLUOROCYCLOBUTANES) AND POLYMERIC CYANATES Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2001-01-11 WO disclosed
WO-2001002880-A1 OPTICAL WAVEGUIDES DERIVED FROM A COMBINATION OF POLY(PERFLUOROCYCLOBUTANES) AND POLYMERIC CYANATES PIRELLI CAVI E SISTEMI S.P.A. (IT) 2001-01-11 WO disclosed
EP-1067405-A1 Optical waveguides derived from a combination of poly(perfluorocyclobutanes) and polymeric cyanates Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2001-01-10 EP disclosed
EP-0581268-B1 Flame-retarded thermosetting resin composition, prepregs and electrical laminates made therefrom KANEGAFUCHI CHEMICAL IND (JP) 1997-12-29 EP disclosed
US-5360887-A Polycyanurates made from aromatic cyanate monomers; heat resistance, water proofing, dielectrics KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-11-01 US disclosed
EP-0581268-A1 Flame-retarded thermosetting resin composition, prepregs and electrical laminates made therefrom KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1994-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140206686-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS MYLK, MYLK2, ROCK1 CYP2A6 2816/4885MAPT 92/4885MAOA 2604/4885
US-20230348462-A1 IMIDAZO[4,5-C]QUINOLINE COMPOUNDS AND THEIR USE AS ATM KINASE INHIBITORS ATM, CHEK2, CHEK1 CYP2A6 4414/4885MAPT 2310/4885MAOA 4110/4885
US-20210022340-A1 USE OF PYRIDINE UREA COMPOUND HAVING SNAIL-KILLING ACTIVITY SLC14A1, UACA, UROD CYP2A6 3363/4885MAPT 2676/4885MAOA 2782/4885
US-20180162823-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS MYLK, MYLK2, ROCK1 CYP2A6 2816/4885MAPT 92/4885MAOA 2604/4885
US-20180000788-A1 CYCLIC UREAS AS INHIBITORS OF ROCK MYLK, ROCK1, UACA CYP2A6 4374/4885MAPT 44/4885MAOA 2597/4885
US-20260015328-A1 ATM KINASE INHIBITORS ATM, CHEK2, CHEK1 CYP2A6 4426/4885MAPT 1465/4885MAOA 3817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.